CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Amneal Pharmaceuticals of New York, LLC recalls Exenatide Injection

Read the official FDA notice

Published
30 Sept 2026
Units affected
5,694 pens
Agency
FDA
Country
United States

The hazard

Defective Delivery System: Possibility of no medication in the prefilled pen.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1

Brand / company
Amneal Pharmaceuticals of New York, LLC
Codes / lots
Lot #: AP250095A, Exp 2/28/2027
Distribution
USA Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 30 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.